3026-69-5

Basic information

• Product Name: Dimethyldioctylammonium bromide
• Synonyms: Dioctyldimethylaminium·bromide;dimethyl(dioctyl)azanium bromide;DIMETHYLDIOCTYLAMMONIUM BROMIDE;DIOCTYLDIMETHYLAMMONIUM BROMIDE
• CAS NO: 3026-69-5
• Molecular Formula: Br*C₁₈H₄₀N
• Molecular Weight: 350.42
• EINECS: 221-189-8
• Product Categories: Ammonium Bromides (Quaternary);Quaternary Ammonium Compounds
• Mol File: 3026-69-5.mol
• Article Data: 3

Chemical Properties

• Melting Point: 60-68 °C
• Appearance: /
• Storage Temp.: Inert atmosphere,Room Temperature
• Solubility: Chloroform (Slightly, Heated), Methanol (Slightly)
• Stability: Hygroscopic
• CAS DataBase Reference: Dimethyldioctylammonium bromide(CAS DataBase Reference)
• NIST Chemistry Reference: Dimethyldioctylammonium bromide(3026-69-5)
• EPA Substance Registry System: Dimethyldioctylammonium bromide(3026-69-5)

Safety Data

• Statements: 36/37/38
• Safety Statements: 26-36/37/39
• Hazardous Substances Data: 3026-69-5(Hazardous Substances Data)

Usage

Uses

Dimethyl(dioctyl)azanium Bromide is an antibacterial dishwashing detergent compound.

InChI:InChI=1/C18H40N.BrH/c1-5-7-9-11-13-15-17-19(3,4)18-16-14-12-10-8-6-2;/h5-18H2,1-4H3;1H/q+1;/p-1

Upstream product

• 7378-99-6 N,N-dimethyloctanamide 
• 111-83-1 1-bromo-octane 
• 1120-48-5 n-dioctylamine 

Relevant articles and documents

Stepwise aggregation of dimethyl-di-n-octylammonium chloride in aqueous solutions: From dimers to vesicles

The self-aggregation of dimethyl-di-n-octylammonium chloride, in diluted aqueous solutions, was studied with various experimental and theoretical techniques: zetametry, conductimetry, dimethyl-di-n-octylammonium and chloride-selective electrodes, tensiometry, NMR spectroscopy (1H and DOSY), and molecular modeling (PM3 and molecular dynamic), The combination, of the data obtained by these techniques led us to propose a stepwise aggregation process with increasing concentration: dimers (0.2-10 mM), bilayers (10-30 mM), and finally vesicles (>30mM).

Method of treating arrhythmia

A method of treating re-entrant arrhythmias comprising administering an effective dose of tetra-alkyl quaternary ammonium salt is provided. Pharmaceutical formulations containing a tetra-alkyl quaternary ammonium salt as the active ingredient are disclosed.